一种多二型皮相仿剂破坏了Grb2 SH3C域蛋白与蛋白相互作用,这与乳腺癌有关
James Luccarelli1, Philip C Simister2, Andrew D Hamilton1
1University of Oxford, Department of Chemistry, UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND.
Chembiochem : a European journal of chemical biology
|May 16, 2025
概括
研究人员开发了一种新的非性支架,模仿聚二烯 (PPII) 螺旋,有效地破坏了参与癌细胞生长的关键蛋白质-蛋白质相互作用 (PPI). 这一突破通过准关键信号通路,为癌症提供了新的治疗策略.
科学领域:
- 药用化学 医学化学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 蛋白与蛋白相互作用 (PPI) 对于细胞信号传递至关重要,也是关键的治疗点.
- 模仿蛋白质二次结构,如α螺旋和β片,是调节PPI的一个有希望的策略.
- Grb2和Gab2的聚二烯 (PPII) 螺旋之间的相互作用对各种癌症的细胞生长和增殖至关重要.
研究的目的:
- 介绍第一个用于扩展PPII螺旋体的非基仿真的一般方法.
- 为了展示一种支架,可以复制Gab2的热点侧链的结合.
- 验证使用多种二次结构二模剂来破坏治疗相关的PPI.
主要方法:
- 一个非性脚手架的合理设计,以模仿PPII螺旋.
- 脚手架的功能化,以回顾Gab2热点侧链特征.
- 蛋白质观察核磁共振 (NMR) 来确认结合地点.
- 表面等离子体共振 (SPR) 用于确定结合亲和力.
主要成果:
- 一个新的非基支架成功模仿了扩展的PPII螺旋.
- 设计的皮相仿剂与原生Gab2的同一个部位与Grb2结合.
- 二甲基的结合亲缘关系与原生序列相似.
- 脚手架可以功能化,以结合关键的疏水和离子相互作用.
结论:
- 本研究介绍了非基PPII螺旋模拟的一般策略.
- 开发的类仿制药有效地破坏了Grb2-Gab2相互作用,这是癌症治疗的目标.
- 这项工作支持用于针对PPI的多种二次结构型模拟剂的更广泛应用.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K


